KRAS and familial pancreatic carcinoma: The results showed that the correlations of CD112/TNFRSF14 and KRAS (Figure S1C and D), as well as CD112/TNFRSF14 and TP53 (Figure S1E and F), were actually quite weak and even nonsignificant in pancreatic cancer.